An Examination of the Effect of Registration Errors on FDG-PET Evaluation of Chemotherapy Response in Sarcoma

被引:0
|
作者
Wolsztynski, E. [1 ]
O'Sullivan, F. [1 ]
Roy, S. [1 ]
O'Sullivan, J. [1 ]
Eary, J. F. [2 ]
机构
[1] Univ Coll Cork, Sch Math Sci, Dept Stat, Western Gateway Bldg,Coll Rd, Cork, Ireland
[2] Univ Washington, Dept Radiol, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
Statistical quantitators that summarise standardized uptake value (SUV) distributions are widely used measures of metabolic activity in the analysis of static Positron Emission Tomography (PET) data. Amongst them, SUV mean and total lesion glycolysis (TLG) have been shown to yield a strong prognostic value for many diseases, which contributed to the rapid expansion of PET-based assessment of diagnosis, prognosis and treatment monitoring methodologies. Such measures, however, remain utilized in a point-wise fashion, that is, without a complementary assessment of their accuracy. Without such information, it is not clear that the assessment would be reliable. This raises important questions in particular for prognosis and therapeutic assessment. We consider here a statistical method that was recently proposed for the monitoring of neoadjuvant chemotherapy for sarcoma. This approach consists in pairing pre- and post-therapy scans in order to quantify the response to therapy, in terms of change in mean tracer uptake, along with an associated estimated accuracy. Pairing the uptake information requires co-registering the two sets of images, which most likely introduces a mis-registration error in the analytic framework. We propose to examine the effect of this mis-registration in a quantified analysis where we formulate the problem as a comparison with a classical (unpaired) therapeutic assessment. We demonstrate that mis-registration should not prevent paired-based methodologies. In particular, the derived measure of assessment accuracy remains more powerful even for large typical mis-registration scales. The viability of this method and its effect on prognostic utility are further considered via multivariate Cox survival analyses on a clinical dataset of 50 sarcoma studies with extensive follow-up information. Encouraging results suggest this approach could generalize to the analysis of other diseases and imaging modalities.
引用
收藏
页码:2876 / 2880
页数:5
相关论文
共 50 条
  • [1] Evaluation of chemotherapy response in osteosarcoma with FDG-PET
    Hamada, Kenichiro
    Tomita, Yasuhiko
    Inoue, Atsuo
    Fujimoto, Tetsuho
    Hashimoto, Nobuyuki
    Myoui, Akira
    Yoshikawa, Hideki
    Hatazawa, Jun
    ANNALS OF NUCLEAR MEDICINE, 2009, 23 (01) : 89 - 95
  • [2] Evaluation of chemotherapy response in osteosarcoma with FDG-PET
    Kenichiro Hamada
    Yasuhiko Tomita
    Atsuo Inoue
    Tetsuho Fujimoto
    Nobuyuki Hashimoto
    Akira Myoui
    Hideki Yoshikawa
    Jun Hatazawa
    Annals of Nuclear Medicine, 2009, 23 : 89 - 95
  • [3] Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer
    de Geus-Oei, L. F.
    van Laarhoven, H. W. M.
    Visser, E. P.
    Hermsen, R.
    van Hoorn, B. A.
    Kamm, Y. J. L.
    Krabbe, P. F. M.
    Corstens, F. H. M.
    Punt, C. J. A.
    Oyen, W. J. G.
    ANNALS OF ONCOLOGY, 2008, 19 (02) : 348 - 352
  • [4] SUV correction for injection errors in FDG-PET examination
    Kouichi Miyashita
    Nobukazu Takahashi
    Takashi Oka
    Shinobu Asakawa
    Jin Lee
    Kazuya Shizukuishi
    Tomio Inoue
    Annals of Nuclear Medicine, 2007, 21 : 607 - 613
  • [5] SUV correction for injection errors in FDG-PET examination
    Miyashita, Kouichi
    Takahashi, Nobukazu
    Oka, Takashi
    Asakawa, Shinobu
    Lee, Jin
    Shizukuishi, Kazuya
    Inoue, Tomio
    ANNALS OF NUCLEAR MEDICINE, 2007, 21 (10) : 607 - 613
  • [6] FDG-PET Evaluation of Response to Treatment
    Kostakoglu, Lale
    PET CLINICS, 2008, 3 (01) : 37 - +
  • [7] FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
    van de Putte, E. E. Fransen
    Vegt, E.
    Mertens, L. S.
    Bruining, A.
    Hendricksen, K.
    van der Heijden, M. S.
    Horenblas, S.
    van Rhijn, B. W. G.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2017, 49 (09) : 1585 - 1591
  • [8] FDG-PET/CT for response evaluation of invasive bladder cancer following neoadjuvant chemotherapy
    E. E. Fransen van de Putte
    E. Vegt
    L. S. Mertens
    A. Bruining
    K. Hendricksen
    M. S. van der Heijden
    S. Horenblas
    B. W. G. van Rhijn
    International Urology and Nephrology, 2017, 49 : 1585 - 1591
  • [9] An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC).
    Van Damme, N.
    De Bruyne, S.
    Mertens, J.
    Van de Wiele, C.
    Ceelen, W. P.
    Smeets, P.
    Ferdinande, L.
    Laurent, S.
    Geboes, K.
    Peeters, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Utility of FDG-PET/CT in the Evaluation of the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy
    Ogino, Kei
    Nakajima, Masanobu
    Kakuta, Miyako
    Hayashi, Mitsuhiro
    Yamaguchi, Satoru
    Tsuchioka, Takashi
    Kubota, Keiichi
    Sakamoto, Setsu
    Kato, Hiroyuki
    INTERNATIONAL SURGERY, 2014, 99 (04) : 309 - 318